P21-17 Safety and effectiveness of mirogabalin for CIPN induced by nab-paclitaxel in patients with pancreatic cancer

Kei Saito,Yousuke Nakai,Kazunaga Ishigaki,Naminatsu Takahara,Tatsunori Suzuki,Ryunosuke Hakuta,Tomotaka Saito,Tsuyoshi Hamada,Suguru Mizuno,Hirofumi Kogure,Mitsuhiro Fujishiro

ANNALS OF ONCOLOGY（2022）

引用 0|浏览3

暂无评分

摘要

Chemotherapy-induced peripheral neuropathy (CIPN) is an adverse event of nab-paclitaxel. The aim of this retrospective study was to assess safety and effectiveness of mirogabalin for CIPN induced by nab-paclitaxel in patients with advanced pancreatic cancer (PC).

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要